ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT00777036
Brief Title: A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib

First Submitted : October 21, 2008
First Submitted that Met QC Criteria : October 21, 2008
First Posted : October 22, 2008 (Estimate)

Results First Submitted : December 6, 2017
Results First Submitted that Met QC Criteria : December 6, 2017
Results First Posted : January 5, 2018

Certification/Extension First Submitted : August 23, 2017
Certification/Extension First Submitted that Met QC Criteria : August 23, 2017
Certification/Extension First Posted : August 24, 2017

Last Update Submitted that Met QC Criteria : January 4, 2018
Last Update Posted : January 29, 2018